L
Description
Clinical-stage biotechnology company headquartered in Pittsburgh, Pennsylvania. Listed on NASDAQ (LIPO). Develops reformulated drugs using liposomal delivery targeted to mucosa to treat diseases of the bladder, oral cavity and other mucosae, with programs for oral GvHD, bladder cancer and hemorrhagic cystitis.